COVID booster vaccinations — both monovalent and bivalent — offer benefits in reducing the risk for severe outcomes of COVID among patients with autoimmune diseases, a US real-world study shows.

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes ...

SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current ...

The COVID-19 vaccines developed for the 2024-2025 respiratory disease season were around 75% effective at preventing ...

For millions of people living with long COVID, symptoms like shortness of breath, mental fog, and deep fatigue continue long after infection, with no clear explanation. Now, a group of leading ...

Work-related factors play a significant and independent role in the risk of developing long COVID, shows a new study based on ...

Research on SARS-CoV-2 in zoo tigers, lions, and hyenas shows rapid viral evolution and adaptation, offering insights into cross-species transmission dynamics.

A new investigation published in JAMA examines how COVID-19 vaccination affects maternal and perinatal outcomes among ...

A zoo outbreak shows how SARS-CoV-2 rapidly evolves in animals, revealing why monitoring COVID-19 in wildlife is vital for ...

Research from Thailand shows high long COVID prevalence in hospitalized patients, with severe illness increasing risk and ...